THE ISSUES surrounding the use of inhaled ther-apy in children are essentially the same as
those in adults. Patients must be given a device that they can and will use effectively—the …

THE PREVALENCE OF CHILDHOOD ASTHMA has increased considerably in Australia and
other industrialized countries over the last few decades. 1–3 Most childhood asthma begins …

An increasing number of patients are dependent on aerosolized therapy to manage
pulmonary diseases, including asthma, cystic fibrosis, and pulmonary arterial hypertension …

Multiple types of aerosol devices are commonly used for the administration of medical
aerosol therapy to patients with pulmonary diseases. All of these devices have been shown …

Inhaled medications are widely accepted as being the optimal route for treating pediatric
respiratory diseases, a leading cause of hospitalization and death. Despite jet nebulizers …

Aerosol therapy: regimen and device compliance in daily practice. - Abstract - Europe PMC
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …

The lung and conducting airways are ideal portals for drug delivery. The airways are easily
accessible by oral or nasal inhalation; the airway and alveolar surface is large, allowing for …

Despite extensive use of aerosol therapy to treat infants and young children with respiratory
disease, our knowledge of factors influencing drug delivery in this age group remains …

Nebulizers have, until recently, been the mainstay of drug delivery by inhalation in babies
and young children. The willingness of a young child to cooperate, however, is limited and …

Using aerosolized medications for the treatment of children has gained importance over the
years. However, aerosol drug delivery to infants and pediatrics is not an easy task as it has …